MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.yjmcc.2017.08.013

Медицинская библиотека · Journal of molecular and cellular cardiology · 2017

MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.

Martinez Eliana C, Lilyanna Shera, Wang Peipei, Vardy Leah A, Jiang Xiaofei, Armugam Arunmozhiarasi, Jeyaseelan Kandiah, Richards Arthur Mark

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

RATIONALE: Myocardial infarction (MI) triggers a dynamic microRNA response with the potential of yielding therapeutic targets.

OBJECTIVE

We aimed to identify novel aberrantly expressed cardiac microRNAs post-MI with potential roles in adverse remodeling in a rat model, and to provide post-ischemic therapeutic inhibition of a candidate pathological microRNA in vivo.

METHODS AND

RESULTS

Following microRNA array profiling in rat hearts 2 and 14days post-MI, we identified a time-dependent up-regulation of miR-31 compared to sham-operated rats. A progressive increase of miR-31 (up to 91.4±11.3 fold) was detected in the infarcted myocardium by quantitative real-time PCR. Following target prediction analysis, reporter gene assays confirmed that miR-31 targets the 3´UTR of cardiac troponin-T (Tnnt2), E2F transcription factor 6 (E2f6), mineralocorticoid receptor (Nr3c2) and metalloproteinase inhibitor 4 (Timp4) mRNAs. In vitro, hypoxia and oxidative stress up-regulated miR-31 and suppressed target genes in cardiac cell cultures, whereas LNA-based oligonucleotide inhibition of miR-31 (miR-31i) reversed its repressive effect on target mRNAs. Therapeutic post-ischemic administration of miR-31i in rats silenced cardiac miR-31 and enhanced expression of target genes, while preserving cardiac structure and function at 2 and 4weeks post-MI. Left ventricular ejection fraction (EF) improved by 10% (from day 2 to 30 post-MI) in miR-31i-treated rats, whereas controls receiving scrambled LNA inhibitor or placebo incurred a 17% deterioration in EF. miR-31i decreased end-diastolic pressure and infarct size; attenuated interstitial fibrosis in the remote myocardium and enhanced cardiac output.

CONCLUSION

miR-31 induction after MI is deleterious to cardiac function while its therapeutic inhibition in vivo ameliorates cardiac dysfunction and prevents the development of post-ischemic adverse remodeling.

Для цитирования: Martinez Eliana C, Lilyanna Shera, Wang Peipei, Vardy Leah A, Jiang Xiaofei, Armugam Arunmozhiarasi, Jeyaseelan Kandiah, Richards Arthur Mark. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.. Journal of molecular and cellular cardiology. 2017. DOI: 10.1016/j.yjmcc.2017.08.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.